Administration of amyloid β-peptides into the medial septum of rats decreases acetylcholine release from hippocampus in vivo
- 4 February 1994
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 636 (1), 162-164
- https://doi.org/10.1016/0006-8993(94)90193-7
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Implants containing β-amyloid protein are not neurotoxic to young and old rat brainNeurobiology of Aging, 1992
- Failure of beta-amyloid protein fragment 25–35 to cause hippocampal damage in the ratNeurobiology of Aging, 1992
- In vivo neurotoxicity of beta-amyloid [β(1–40)] and the β(25–35) fragmentNeurobiology of Aging, 1992
- Action of amyloid beta-protein on protein kinase C activityLife Sciences, 1991
- Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's diseaseJournal of Molecular Biology, 1991
- Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin NeuropeptidesScience, 1990
- The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptorNature, 1987
- The Cholinergic Hypothesis of Geriatric Memory DysfunctionScience, 1982
- Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.BMJ, 1978
- A rapid radiochemical method for the determination of choline acetyltransferaseJournal of Neurochemistry, 1975